Informations: Ceci n’est pas la version la plus récente du modèle de données. Vous trouverez un aperçu de la version à gauche, sous Versions. Vous trouverez la version la plus actuelle ici.
Informations:
Erreur:
ID
24622
Description
Evaluation of Contrast-Enhanced Ultrasound Imaging for the Early Estimate of Bevacizumab Effect on Colorectal Cancer Liver Metastases; ODM derived from: https://clinicaltrials.gov/show/NCT00489697
Lien
https://clinicaltrials.gov/show/NCT00489697
Mots-clés
Versions (2)
- 09/08/2017 09/08/2017 -
- 17/09/2021 17/09/2021 -
Téléchargé le
9 août 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Metastatic Colorectal Cancer NCT00489697
Eligibility Metastatic Colorectal Cancer NCT00489697
- StudyEvent: Eligibility
Similar models
Eligibility Metastatic Colorectal Cancer NCT00489697
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Colorectal Carcinoma
Item
histologically confirmed colorectal tumor
boolean
C0009402 (UMLS CUI [1])
First line treatment Chemotherapy | bevacizumab
Item
first line treatment by a bevacizumab based chemotherapy
boolean
C1708063 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C0796392 (UMLS CUI [2])
C0392920 (UMLS CUI [1,2])
C0796392 (UMLS CUI [2])
Target Secondary malignant neoplasm of liver Size | Ultrasonography | X-Ray Computed Tomography | Magnetic Resonance Imaging
Item
target hepatic metastases of size lower than 5 cm and higher than 5 mm detected by conventional ultrasonography and ct or mri
boolean
C1521840 (UMLS CUI [1,1])
C0494165 (UMLS CUI [1,2])
C0456389 (UMLS CUI [1,3])
C0041618 (UMLS CUI [2])
C0040405 (UMLS CUI [3])
C0024485 (UMLS CUI [4])
C0494165 (UMLS CUI [1,2])
C0456389 (UMLS CUI [1,3])
C0041618 (UMLS CUI [2])
C0040405 (UMLS CUI [3])
C0024485 (UMLS CUI [4])
Life Expectancy
Item
life expectancy > 2 months
boolean
C0023671 (UMLS CUI [1])
WHO performance status scale
Item
oms status =< 2
boolean
C1298650 (UMLS CUI [1])
Major surgery | Incisional biopsy | Traumatic injury
Item
major surgery, open biopsy, or significant traumatic injury within 28 days prior to day 0
boolean
C0679637 (UMLS CUI [1])
C0184922 (UMLS CUI [2])
C3263723 (UMLS CUI [3])
C0184922 (UMLS CUI [2])
C3263723 (UMLS CUI [3])
Informed Consent
Item
informed consent signed
boolean
C0021430 (UMLS CUI [1])
Target Lesion of liver Absent | Ultrasonography
Item
no target hepatic lesion detected by conventional ultrasonography
boolean
C1521840 (UMLS CUI [1,1])
C0577053 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0041618 (UMLS CUI [2])
C0577053 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0041618 (UMLS CUI [2])
Bevacizumab Prior Therapy
Item
prior bevacizumab treatment
boolean
C0796392 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,2])
Chemotherapy Advanced disease
Item
prior chemotherapy treatment for advanced disease
boolean
C0392920 (UMLS CUI [1,1])
C0679246 (UMLS CUI [1,2])
C0679246 (UMLS CUI [1,2])
Heart Diseases | Myocardial Infarction | Cerebrovascular accident | Angina, Unstable | Congestive heart failure Poorly controlled New York Heart Association Classification | Endocarditis | Prosthetic valve | Medical contraindication Sulfur Hexafluoride
Item
clinically significant cardiac disease (e.g. myocardial infarction or stroke within 12 months, unstable angina, new york heart association (nyha) grade ii or greater congestive heart failure not well controlled with medication, endocarditis and prosthetic valve) and any contraindications in sulphur hexafluoride administration
boolean
C0018799 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0018802 (UMLS CUI [5,1])
C3853134 (UMLS CUI [5,2])
C1275491 (UMLS CUI [5,3])
C0014118 (UMLS CUI [6])
C0336548 (UMLS CUI [7])
C1301624 (UMLS CUI [8,1])
C0038779 (UMLS CUI [8,2])
C0027051 (UMLS CUI [2])
C0038454 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0018802 (UMLS CUI [5,1])
C3853134 (UMLS CUI [5,2])
C1275491 (UMLS CUI [5,3])
C0014118 (UMLS CUI [6])
C0336548 (UMLS CUI [7])
C1301624 (UMLS CUI [8,1])
C0038779 (UMLS CUI [8,2])
Blood pressure measurement
Item
blood pressure >= 180/110 mmhg
boolean
C3826646 (UMLS CUI [1])
Aspirin Daily chronic | Non-Steroidal Anti-Inflammatory Agents Daily chronic
Item
daily and chronic treatment by aspirin or ains
boolean
C0004057 (UMLS CUI [1,1])
C0332173 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0003211 (UMLS CUI [2,1])
C0332173 (UMLS CUI [2,2])
C0205191 (UMLS CUI [2,3])
C0332173 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0003211 (UMLS CUI [2,1])
C0332173 (UMLS CUI [2,2])
C0205191 (UMLS CUI [2,3])
Major surgery Need Anticipated
Item
anticipation of need for major surgical procedure within 7 days prior day 0
boolean
C0679637 (UMLS CUI [1,1])
C0027552 (UMLS CUI [1,2])
C3840775 (UMLS CUI [1,3])
C0027552 (UMLS CUI [1,2])
C3840775 (UMLS CUI [1,3])
Urine protein test
Item
urine protein > 1g/24 hours
boolean
C0262923 (UMLS CUI [1])
Medical contraindication Bevacizumab
Item
any contraindication in enhancing bevacizumab treatment
boolean
C1301624 (UMLS CUI [1,1])
C0796392 (UMLS CUI [1,2])
C0796392 (UMLS CUI [1,2])
Communicable Diseases Uncontrolled Serious | Illness Uncontrolled Serious
Item
serious, uncontrolled, concurrent infection(s) or illness(es)
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0221423 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0205404 (UMLS CUI [2,3])
C0205318 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,3])
C0221423 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0205404 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
pregnant and lactating woman
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])